How do you talk to patients about psychedelic clinical trials for the treatment of major depressive disorder or PTSD?
When do you consider referring a patient to a clinical trial? How have patients responded to being offered trial participation? What has your experience been with patient selection and eligibility?
1 Answer
Mednet MemberInvited Expert
Psychiatry · Yale School Of Medicine Pitt Lab
Answered on
These discussions usually come up with patients who have not been satisfied with prior pharmacologic treatments for depression or PTSD. I see my role as educating patients so that they can make the choice that is best for them. I will talk to them about the potential risks and benefits of psychedeli...
Join for free or sign in to see the full answer